Abstracts tagged "Quality improvement and vaccines"

Abstract Number: 344 • 2018 ACR/ARHP Annual Meeting
Use of Lean Six-Sigma Methodologies to Improve Pneumococcal Vaccination Rates Among Immunocompromised Veterans with Rheumatologic Diseases: A Quality Improvement Project
Melissa Swee¹, Jaime Wilson² and Bharat Kumar³, ¹Transplant Nephrology, University of Iowa, Iowa City, IA, ²Iowa City Veterans Affairs Medical Center, Iowa City, IA, ³Internal Medicine-Division of Immunology, University of Iowa, Iowa City, IA
Background/Purpose: Pneumonia is a leading cause of morbidity and mortality in the United States among immunocompromised individuals with rheumatologic diseases. Despite the publication of Advisory…
Abstract Number: 466 • 2018 ACR/ARHP Annual Meeting
Improving Pneumococcal Vaccination Rates in Childhood-Onset SLE Patients at a Large Tertiary Care Center: The Path to Creating a More Sustainable Model of Vaccination with the Help of EMR
Saimun Singla and Marietta M. De Guzman, Pediatric Immunology, Allergy and Rheumatology, Baylor College of Medicine, Texas Children's Hospital, Houston, TX
Background/Purpose: Streptococcus pneumonia is a leading cause of illness in children worldwide and can lead to death in those with an immunosuppressed status. Given the…
Abstract Number: 1241 • 2018 ACR/ARHP Annual Meeting
Pneumococcal Vaccination Quality Improvement Initiative within a Rheumatology Clinic at an Academic Medical Center
Ali Goodson¹, Bonita Libman², Alana Nevares³, Melinda Edwards² and Amanda Kennedy⁴, ¹Pharmacy, The University of Vermont Medical Center, Burlington, VT, Afghanistan, ²Medicine/Rheumatology, University of Vermont Medical Center, Burlington, VT, ³Rheumatology, University of Vermont Medical Center, Burlington, VT, ⁴Internal Medicine, University of Vermont Medical Center, Burlington, VT
Background/Purpose: Rheumatology patients are at an increased risk of infection secondary to immunosuppressive medications used for disease management. However, vaccination is underutilized and rates remain…
Abstract Number: 2026 • 2017 ACR/ARHP Annual Meeting
Pneumococcal Vaccination Rates: Improving Safety in Immunocompromised Patients
Shanley O'Brien and Paul Schmidt, Department of Internal Medicine, Division of Allergy, Clinical Immunology, & Rheumatology, Kansas University Medical Center, Kansas City, KS
Background/Purpose: Streptococcus pneumoniae is the most common cause of bacterial pneumonia.1 Invasive pneumococcal infections carry a 10% mortality rate, which is higher in the immunosuppressed.1…
Abstract Number: 2027 • 2017 ACR/ARHP Annual Meeting
Pre-Visit Planning Improves Pneumococcal Vaccination in Patients with Childhood-Onset Systemic Lupus Erythematosus
Kelly Wise¹, Fatima Barbar-Smiley², Stephanie Lemle², Darby MacDonald², Ohoud AlAhmed³, Evan Mulvihill⁴, William Cotton², Monica Ardura², Cagri Yildirim-Toruner⁵ and Vidya Sivaraman^6,7, ¹Pharmacy/Rheumatology, Nationwide Children's Hospital, Columbus, OH, ²Nationwide Children's Hospital, Columbus, OH, ³Pediatrics, Nationwide Children's Hospital, Columbus, OH, ⁴Pediatrics and Rheumatology, Nationwide Children's Hospital and The Ohio State University, Columbus, OH, ⁵Rheumatology, Nationwide Children's Hospital, Columbus, OH, ⁶Pediatric Rheumatology, Nationwide Children's Hospital, Columbus, OH, ⁷Pediatrics, The Ohio State University, COLUMBUS, OH
Background/Purpose: Patients with Systemic Lupus Erythematosus (SLE) lupus are up to 13 times more likely to develop invasive pneumococcal infections, resulting in increased morbidity and…
Abstract Number: 2042 • 2016 ACR/ARHP Annual Meeting
Improving the Overall Pneumococcal Vaccination Rate in Lupus Patients at the Rheumatology Clinic
Shivani Garg¹, Aliza Lipson² and Katina Tsagaris³, ¹Rheumatology, Emory University, Atlanta, GA, ²Rheumatology, EMORY UNIVERSITY, atlanta, GA, ³Rheumatology, EMORY UNIVERSITY, Atlanta, GA
Background/Purpose: The risk of developing invasive pneumococcal pneumonia is 13 times higher in Lupus patients in comparison with general population. CDC anticipates 7.6 Million-Dollar medical…
Abstract Number: 425 • 2016 ACR/ARHP Annual Meeting
Improving Pneumococcal Vaccination Rates for Immunosuppressed Patients in an Academic Rheumatology Clinic
Alison Bays¹, Renuka R. Nayak², Sara Murray³, Darlene Young⁴, Gabriela Schmajuk⁵, Jinoos Yazdany⁶ and Andrew Gross⁷, ¹Rheumatology, University of Washington, Seattle, WA, ²Rheumatology, UCSF, San Francisco, CA, ³Medicine, UCSF, San Francisco, CA, ⁴Medicine/Rheumatology, UCSF, San Francisco, CA, ⁵San Francisco VA Medical Center, University of California, San Francisco, San Francisco, CA, ⁶Medicine/Rheumatology, University of California, San Francisco, San Francisco, CA, ⁷Medicine/Rheumatology, University of California San Francisco, San Francisco, CA
Background/Purpose: Patients with autoimmune conditions have higher rates of pneumococcal disease and they are often immunosuppressed. In 2014, the Advisory Committee on Immunization Practices issued…
Abstract Number: 426 • 2016 ACR/ARHP Annual Meeting
Herpes Zoster Vaccine: A Quality Improvement Study in Rheumatoid Arthritis Patients
Rochella A. Ostrowski and Hina Chaudhry, Rheumatology, Loyola University Medical Center, Maywood, IL
Herpes Zoster Vaccine: A Quality Improvement Study in Rheumatoid Arthritis Patients Chaudhry, Hina S.; Ostrowski, Rochella A. Division of Allergy, Immunology, and Rheumatology, Loyola University…
Abstract Number: 1028 • 2015 ACR/ARHP Annual Meeting
Improving Pneumococcal Immunization Rates Among Immunocompromised Adolescent Patients at a Tertiary Care Children’s Hospital
Michal Feldon¹, Adam Furnier², Corinne Lehmann³, Bradford Fletcher⁴, Jack Kues⁵, Barbara Speer⁵, Sandy Kramer⁶, Pamela Morgan⁷, Lois Siegle⁸, Rebecca Brady⁹ and Jennifer L. Huggins⁶, ¹Pediatric Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, ²Quality Improvement Systems, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, ³Division of adolescent and transitional medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, ⁴Division of pharmacy, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, ⁵Continuing medical education department, University of Cincinnati, Cincinnati, OH, ⁶Division of Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, ⁷Division of gastroenterology, hepatology and nutrition, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, ⁸department of gastroenterology, hepatology and nutrition, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, ⁹Division of infectious diseases, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
Background/Purpose: Streptococcus pneumoniae is a leading cause of severe infections, including pneumonia and meningitis, among immunocompromised patients. The administration of both the 13-valent pneumococcal conjugate…
Abstract Number: 2502 • 2015 ACR/ARHP Annual Meeting
Implementation of New Pneumococcal Vaccination Recommendations in an Academic Rheumatology Clinic
Alison Bays¹, Renuka Nayak², David I. Daikh³, Jinoos Yazdany⁴ and Gabriela Schmajuk⁵, ¹Rheumatology, University of Washington, Seattle, WA, ²Rheumatology, UCSF, San Francisco, CA, ³Rheumatology, UCSF/VA Medical Center, San Francisco, CA, ⁴Rheumatology, UCSF, SF, CA, ⁵San Francisco VA Medical Center, University of California, San Francisco, San Francisco, CA
Background/Purpose: Invasive pneumococcal disease is approximately four times more common among patients with rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE) compared to healthy counterparts.…
Abstract Number: 2503 • 2015 ACR/ARHP Annual Meeting
Improved Pneumococcal Vaccination in Rheumatoid Arthritis Patients in an Urban Academic Rheumatology Clinic
Swathi B. Reddy¹, Una E. Makris², Kara Prescott³ and E. Blair Solow², ¹Internal Medicine, Division of Rheumatic Diseases, UT Southwestern Medical Center, Dallas, TX, ²Rheumatology, UT Southwestern Medical Center, Dallas, TX, ³Internal Med - Rheumatology, Dallas VA Medical Center, Dallas, TX
Background/Purpose: Immunosuppressed patients are at higher risk for infections compared to the general population. Vaccines decrease morbidity and mortality, however vaccination status is not consistently…
Abstract Number: 1349 • 2014 ACR/ARHP Annual Meeting
A Decision Support Tool to Improve Herpes Zoster Vaccination Rates Among Patients Starting Biologic Medications
Sara Schoenfeld¹, Eli Miloslavsky¹, Weihong Yang¹, Naina Rastalsky¹, Mollie Carruthers¹, Zachary Wallace¹, Traci Powers¹, Marcy Bolster² and Deborah Collier¹, ¹Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Boston, MA, ²Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital / Harvard Medical School, Boston, MA
Background/Purpose Herpes zoster infection causes serious morbidity and mortality in immunocompromised patients. Vaccination reduces the risk of zoster infection by up to 40% among patients…
Abstract Number: 1345 • 2014 ACR/ARHP Annual Meeting
Improving Pneumococcal Immunization Rates for Patients on Immunosuppressant Medications at an Academic Rheumatology Clinic
Lauren Dudley¹, Stephen Liu², Krista Merrihew¹, Jocelyn Verrill¹ and Lin Brown¹, ¹Rheumatology, Dartmouth-Hitchcock Medical Center, Lebanon, NH, ²Internal Medicine, Dartmouth-Hitchcock Medical Center, Lebanon, NH
Background/Purpose: Patients with rheumatologic diseases are frequently placed on immunosuppressant medications which increase their risk of developing Streptococcus pneumoniae infections. The Advisory Committee on Immunization…
Abstract Number: 1343 • 2014 ACR/ARHP Annual Meeting
A Quality Improvement Initiative to Improve Pneumococcal Vaccination Rates in Immunosuppressed Patients
Melissa Bussey¹ and Rochella A. Ostrowski², ¹Rheumatology, Division of Rheumatology, Loyola University Medical Center, Maywood, IL, ²Rheumatology, Loyola University Medical Center, Maywood, IL
Background/Purpose Patients with autoimmune diseases are at increased risk of complicated infections, and immunomodulating treatment regimens further enhance this risk. Many of these infections,…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].